Dramatic rise in high blood pressure contributes to many U.S. deaths
the ONA take:
Deaths related to high blood pressure have sharply risen over the last 13 years, according to recent data from the CDC’s National Center for Health Statistics.
In the CDC’s report, hypertension-related deaths was found to have increased by 61.8 percent from 2000 to 2013, and the rate of incidence rose for both sexes aged 45 or older.
The researchers, who pulled their data from national cause-of-death files, counted any mention of hypertension on death certificates as a hypertension-related death.
Overall, one out of six hypertension-related deaths was due to high blood pressure as the underlying cause.
However, the report also found that the proportion of deaths where heart disease was the underlying cause of death had dropped by about 6 percent, while those with stroke as an underlying cause dropped by about 5 percent. High blood pressure was still a contributing factor to other deaths.
Deaths as a result of heart disease, stroke, cancer, and diabetes that mentioned hypertension in certificates made up 65 percent of counted deaths in 2000, and 54 percent of those in 2013.
Deaths related to high blood pressure have sharply risen over the last 13 years.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|